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Globally, the commercialisation of plants as observed in their uses by many industries such as the cosmeceutical, nutraceutical and
pharmaceutical ones is gaining more interest and popularity. Mondia whitei is a popular medicinal plant which is endemic to Africa. Since
antiquity, M. whitei has been used by African people to treat various ailments. The roots were used for the treatment of anorexia, stress, bilharzia
and sexual dysfunction as well as for general aches and pains. Researchers have evaluated the efficacy of most of these claims by screening the
M. whitei for biological activities such as antimicrobial, anti-inflammatory and anthelmintic as well as aphrodisiac efficacy. Furthermore,
M. whitei has horticultural, nutritional and other socio-cultural values as reported in countries such as South Africa, Nigeria, Zimbabwe, Kenya,
Uganda and Malawi. As a result of its numerous uses across the African continent, we attempt to explore and assess the economic potential of
M. whitei with emphasis on medicinal values. The root of M. whitei is the most popular organ used in traditional medicine; consequently, this has
resulted in the species becoming rare or threatened with extinction in the wild. Several authors have suggested solutions such as plant or plant part
substitution to overcome the over-harvesting problem. The application of biotechnology techniques such as micropropagation and hairy roots also
remain viable options which are presently being utilised to a lesser extent. Nevertheless, the sustainable harvesting and feasible conservation
strategy for the species remains a major challenge. It is strongly recommended that in as much as the economic potential of M. whitei should be
exploited, more detailed attention and studies should be geared towards its conservation. In order to ensure sustainable use and to derive maximum
economic benefits, it is necessary to have empirical information detailing its ethno-botanical values, conservation status and commercial potential.
© 2011 SAAB. Published by Elsevier B.V. All rights reserved.
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Mondia whitei (Hook.f.) Skeels is a member of the
Apocynaceae (previously in the family Asclepiadaceae),
subfamily Periplocoideae. The species was initially placed in
the genus Chlorocodon, this was later changed to Mondia
because the former name was a homonym used for a genus of
ericacious plants. The genus Mondia Skeels consists of two
species; M. whitei and Mondia ecornuta (N.E.Br.) Bullock.
(Ross, 1978; Venter et al., 2009). Both species have the same⁎ Corresponding author. Tel.: +27 33 2605130; fax: +27 33 2605897.
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0254-6299/$ - see front matter © 2011 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2011.06.010physical appearance however, the structure and number of
corona lobes are the distinguishing features between the two
species (Venter et al., 2009). M. whitei is commonly known as
White's ginger, tonic root or umondi/mundi; a Zulu name from
which the generic name was derived. Interestingly, the specific
epithet ‘whitei’ was in honour of the collector Mr A.S White of
Fundisweni, Natal who motivated the transfer of the species to
the Royal Botanical Gardens, Kew, England for documentation
(Ross, 1978).
M. whitei is an endemic African species useful to the populace
since ancient time. Some of the important uses of M. whitei are
medicinal, cultural and nutritional. Most of the plant material is
collected from the wild and this has contributed significantly to its
vulnerable status. In most countries whereM. whitei is found, the
commercial cultivation of the species is minimal or does not existts reserved.
961A.O. Aremu et al. / South African Journal of Botany 77 (2011) 960–971which has further impacted upon its conservation. In view of the
economic potential ofM.whitei especially the medicinal uses, we
decided to search and collect the available information on the
species via electronic (search engines) and library searches. This
review examines the various studies onM. whitei in an attempt to
highlight the benefits that may be derived from the plant. From
published data, some observed loopholes as well as the neglected
research areas on M. whitei were also identified for possible
attention from researchers. In addition, this review strongly
endorses the commercialisation of M. whitei in South Africa
based on its extensive usage by the local populace. It is hoped that
this review will provide useful material to researchers, conserva-
tionists, policy makers as well as government agencies that
require detailed overview of the general uses, possible conserva-
tion methods and economic potential of M. whitei.
1.1. Morphology of M. whitei
M. whitei is a perennial woody climber reaching 3–6 m high
with twining stems which exudes white latex when cut
(Fig. 1A). It has characteristic large, oppositely positioned
heart-shaped leaves (Fig. 1B). The surface of the leaves are
endowed with soft hairs and distinctive star-shaped stipules
(Ross, 1978). The attractive flowers are reddish purple in colour
and are borne in branched inflorescences (Fig. 1C). Flowers areFig. 1.Mondia whitei (A) creeping and well-supported on an iron bar; (B) twining steassumed to be pollinated by flies and are relatively short-lived
surviving for 3–4 days. The flowering season ranges from
October to March (peaking between November and January)
south of the equator and from May to August (peaking in June
to July) north of the equator (Venter et al., 2009). M. whitei
grows from a large, tuberous rootstock and the roots have a very
distinct vanilla aroma which has been attributed to the presence
of 2-hydroxy-4-methoxybenzaldehyde (Fig. 1D). The roots
grow laterally and may spread out just beneath the soil surface
covering large areas, making them easy to harvest (Ross, 1978;
Van Wyk and Gericke, 2000). The fruit is an ovoid follicle
which dehisces to release an estimated 180–320 comose seeds
that are wind-dispersed (Ross, 1978). A more comprehensive
history, morphology and taxonomy of M. whitei is available
(Venter et al., 2009).
2. Distribution of M. whitei
M. whitei is endemic in almost all African regions with the
exception of the northern part of the continent. M. whitei
predominantly occurs in moist to wet forests. It is found in
vegetation types that range from swamp forest, swampy
shrubby grassland and riverine forest to disturbed forest, at
altitudes from sea level to 1800 m (Venter et al., 2009). In West
Africa, the species is commonly found in Guinea, Ghana andms with leaves; (C) young buds and fully opened flowers; and (D) mature roots.
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Cameroon. Kenya, Tanzania and Uganda are countries where
M. whitei is found in East Africa (McGeoch et al., 2008; Venter
et al., 2009). South Africa, Malawi, Angola, Mozambique and
Zimbabwe are southern African countries where this species has
been recorded (Venter et al., 2009). In South Africa,M. whitei is
mainly found in the KwaZulu-Natal and Limpopo Provinces. In
KwaZulu-Natal, the species is restricted to the midlands as well
as lower, frost-free elevations; often near the coastal areas
where colonies are becoming scarce in protected swamps
(Crouch et al., 1998a). Herbarium specimens examined by
Venter (Venter et al., 2009) indicated locations such as Mkuze
Nature Reserve (confluence of Mkuze and Msunduzi rivers),
Empangeni village and Mfundisweni (formerly Fundisweni) as
areas whereM. whitei occurs in the Province of KwaZulu-Natal.
3. Uses of M. whitei
3.1. Medicinal uses
M. whitei is a versatile plant with many uses which are either
documented or passed down to subsequent generations by word
of mouth. Across various ethnic groups in Africa, M. whitei is
known as a mild laxative, to ease abdominal pains, alleviate
nausea as well as for the treatment of fever, bilharzia and sexual
dysfunction (Crouch et al., 1998a). Besides ancient documen-
tation of the uses of M. whitei (Gelfand et al., 1985; Watt and
Breyer-Brandwijk, 1962), more recent ethno-botanical surveys
continually cite the local use of the species. A root decoction of
M. whitei is documented to; induce labour in Uganda (Ssegawa
and Kasenene, 2007), fight malaria infection in Benin and
Nigeria (Hermans et al., 2004; Odugbemi et al., 2007), eradicate
worm infestation (anthelmintics) in Nigeria (Idu et al., 2010)
and cure male infertility in Cameroon (Focho et al., 2009). In
Kenya, a survey showed that M. whitei is practically used for
many problems, for example; ringworms, skin diseases,
stomach worms, heart diseases and asthma (McGeoch, 2004).
In addition, the species is used by unspecified groups in South
Africa to treat stress and tension in adults (Van Wyk and
Gericke, 2000). Stafford et al. (2008) highlighted that South
Africans use M. whitei to stimulate appetite, as an aphrodisiac,
and for treatment of fits in children.
A number of scientific studies involving the use of different
solvent extracts ofM.whitei parts have been performed by various
workers. These include biological assays investigating the
aphrodisiac, antimicrobial, anti-inflammatory, anti-tyrosinase
and antioxidant activities (Table 1). Most of the assays attempt
to investigate the efficacy of the plant extracts against major
health problems encountered by humans.M. whitei extracts have
shown great potential in most of the biological activities
investigated thus validating most of its traditional uses since
ancient times. Particularly, the investigation for aphrodisiac
efficacy of M. whitei roots, yielded positive results (Lampiao,
2009; Martey and He, 2010). Some aldehydes are cytotoxic
against certain types of cancer in vitro. As this may be due to
inhibition of tyrosinase, it was decided to investigateM.whitei for
possible anticancer activity against various cell lines (Kintziosand Barberaki, 2004). The efficacy of M. whitei extracts against
mental, neurological or behavioural problems via in vivo and in
vitro systems has also received intense investigation by our group
(RCPGD) in collaboration with the Department of Medicinal
Chemistry, University of Copenhagen, Denmark. Recently, a
monoterpene lactone (−)-loliolide (4) which was responsible for
in vitro serotonin transporter (SERT) affinity was isolated
(Neergaard et al., 2010). Owing to the unique nature of the
isolated compound (4), further studies to elucidate the SERT
inhibition mechanism as well as the in vivo efficacy are on-going.
Although most studies investigating the biological activity of
numerous medicinal species such as M. whitei are based on one
plant one target approach, traditional medicine often uses the
combination of two or more plant extracts at a time. As a result
of this practice, a number of studies have also investigated
formulations which consisted ofM. whitei in treatment of sickle
cell anaemia (Egunyomi et al., 2009) and sexual dysfunctions
(Gundidza et al., 2009). The authors reported favourable results
with formulations containing M. whitei however, the impact of
the M. whitei in the observed responses remain very difficult to
explain due to the complex nature of the interaction with other
plant species in the formulation.
3.2. Nutritional properties
From antiquity, various organ parts ofM.whitei such as leaves,
roots and tubers have been utilised as food. As documented by
Gerstner (1941), the Zulus in South Africa use the roots as an
appetite stimulant. Several flavoured drinks have been obtained
from the roots. Duringweddings in severalWest Africa countries,
the roots are used to make a beverage similar to ginger beer or are
brewed in alcohol to make an energising drink. In South Africa,
the root is sometimes cookedwithmeat to enhance the flavour and
also used as a tea (Crouch et al., 1998a; Van Wyk and Gericke,
2000). In Kenya, the roots are eaten fresh or dried, initially tasting
rather hot and bitter then slightly sweeter afterwards (Mukonyi,
2002). In Angola, M. whitei served as an alternative food for the
early Portuguese and their neighbouring locals who boiled the
leaveswith butter or olive oil serving as a substitute for spinach. In
KwaZulu-Natal (South Africa), leaves are eaten as a pot herb or
imifino and the dried powdered leaves are added to food as a
condiment (Crouch et al., 1998a). Mukonyi (2002) reported that
M. whitei leaves have more nutritional value than other regularly
used animal feeds, but it proved unpalatable to goats. Neverthe-
less, it seemed to increase milk production in Friesian cows. In
Uganda, the tubers are commonly consumed; however the taste
varies depending on the age of the plant. The young tubers are
sweet tasting, whereas mature tubers have a slightly bitter taste
probably because of the accumulation of secondary metabolites
(McGeoch, 2004).
M. whitei contains vitamins A, D, K and E as well as
magnesium, zinc, iron, calcium and protein (Tables 2 and 3). As
a result, M. whitei may be a readily and affordable alternative
source for the prevention of micronutrient deficiencies
especially among poor populations. Youkeu (2008) estimated
the nutritional value of M. whitei to be 280.8 kcal/100 g. In
addition, an in vivo study to determine the effect of M. whitei
Table 1
Pharmacological studies on Mondia whitei across various African countries with biological activities assayed and resultant effects.
Country of
collection
Part
used
Extracting solvent Biological activity evaluated Observations and results Reference
Cameroon Root
bark
Water Reversible in vivo antispermatogenic and antifertility activities Inhibition of spermatogenesis and
reduced fertility
Watcho
et al., 2001
Cameroon Roots Water In vivo androgenic activity An increase in serum and intra-testicular
testosterone levels after chronic treatment
Watcho
et al., 2004
Cameroon Roots Hexane In vivo androgenic activity Had a reversible androgenic effect and
potentiate the action of norepinephrine
on rat vas deferens
Watcho
et al., 2005
Cameroon Roots Hexane, methylene
chloride: methanol
In vitro androgenic activity Hexane fraction had a significant
inhibition against the contractions induced by
potassium chloride (KCl) and adrenaline-induced
contraction in isolated vas deferens
Watcho
et al., 2006
Cameroon Roots Hexane, water and
methylene chloride
In vitro pro-erectile activity Methylene chloride fraction relaxed the smooth muscle
of guinea pig corpus cavernosum pre-contracted
with phenylephrine
Watcho
et al., 2007a
Cameroon Roots Hexane, water In vivo androgenic activity Extracts caused an increase in mount,
intromission and erectile frequencies of the
inexperienced male rats
Watcho
et al., 2007b
Cameroon Roots Water In vitro antioxidant, anti-amylase and anti-lipase activities No significant bioactivity was detected in
the three assays
Etoundi
et al., 2010
Cameroon Roots Methanol In vitro antioxidant activity (Hydroxyl radical scavenging, ferric
ion reducing power and free radical
scavenging activity)
Extract had high hydroxyl radical
scavenging activity while antioxidant activity
in other assays were low
Abdou Bouba
et al., 2010
Ghana Roots Ethanol In vivo aphrodisiac activity A dose of 200 mg/kg improved and sustained
erection probably through activation/stimulation
of nitric oxide synthase (NOS) activity
Quasie
et al., 2010
Kenya Roots Methanol In vitro tyrosinase-inhibitory activity Inhibition of the oxidation of L-3,4-
dihydroxyphenylalanine (L-DOPA)
with ID50 of 4.3 μg/ml
Kubo
and Kinst-Hori,
1999
Kenya Roots Hexane, methanol,
water
In vitro anti-inflammatory activity Hexane and methanol extracts had high
(above 80%) cyclooxygenase-1 (COX-1)
enzyme inhibition
Matu
and Van Staden,
2003
Kenya Roots Hexane, methanol,
water
In vitro antibacterial activity No significant antibacterial activity detected
using the agar disc-diffusion assay
Matu
and Van Staden,
2003
Kenya Leaves Hexane, methanol,
water
In vitro anti-inflammatory activity Methanol and water extracts had moderate
(above 65%) COX-1 inhibition
Matu
and Van
Staden, 2003
(continued on next page)
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Table 1 (continued)
Country of
collection
Part
used
Extracting solvent Biological activity evaluated Observations and results Reference
Kenya Leaves, Hexane, methanol,
water
In vitro antibacterial activity No significant antibacterial activity detected in
agar disc-diffusion assay
Matu
and Van
Staden, 2003
Malawi Roots Water In vitro human sperm motility parameters An increase in the total spermatozoa motility Lampiao
et al., 2008
*Nigeria Roots Water In vitro anti-sickling activity
(using a plant mixture recipe containing 26 other plant species)
Mixture exhibited significant (63.4% inhibition) activity
on sodium metabisulphite induced sickling effect
Egunyomi
et al., 2009
South
Africa
Roots Hexane, ethanol,
water
In vitro antibacterial activity using the disc-diffusion
and microdilution assays
No antibacterial activity were detected
against the four bacteria strains tested
McGaw
et al., 2000
South
Africa
Roots Water In vitro anti-schistosomiasis activity After 1 h, 50 mg/ml water extract
effectively killed the schistosomula
Sparg
et al., 2000
South
Africa
Leaves Ethanol In vitro antidepressant activity via the serotonin reuptake
transport (SERT) assay
Isolation of (−)-loliolide with IC50
value of 977 μM
Neergaard
et al., 2010
South
Africa
Leaves Methanol, water In vitro antiepileptic and anticonvulsant GABAA-benzodiazepine
receptor binding assay
Moderate dose-dependent antiepileptic
and anticonvulsant effect
Risa
et al., 2004
South
Africa
Leaves Ethanol In vitro selective serotonin reuptake inhibitor (SSRI) activity Noteworthy in vitro affinity for the SSRI
binding site exhibiting with an IC50 value
of 0.4 mg/ml
Pedersen
et al., 2006
South
Africa
Leaves Ethanol Antidepressant activity via in vitro [affinity to the SERT and
for inhibitory effects on the SERT, the noradrenalin transporter
(NAT) and the dopamine transporter (DAT)].and in vivo [tail
suspension test (TST) and forced swim test (FST), locomotor
activity] assays
Ethanol extract exhibited significant
antidepressant-like effects in FST assay
Pedersen
et al., 2008
South
Africa
Leaves 70% ethanol, water In vitro antidepressant activity using SERT protein binding assay 70% ethanol extract had moderate inhibitory
effect on neuronal uptake of serotonin
Nielsen
et al., 2004
South
Africa
Flowers 70% ethanol, water In vitro antidepressant activity using SERT protein binding assay Ethanol extract had moderate inhibitory
effect on neuronal uptake of serotonin
Nielsen
et al., 2004
*Zimbabwe Roots Ethanol In vivo aphrodisiac activity (extract used as a formulation:
Mondia whitei+Ekerbegia capensis)
Formulation showed a dose-dependent
direct affect in increasing sexual arousability,
better sexual stimulation and increase in copulatory
efficiency in rats
Gundidza
et al., 2009
* = Indicates studies where M. whitei was investigated as a formulation or in combination with other plant species.
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Table 2
Physicochemical characteristics of dried roots of Mondia whitei.
Physicochemical parameters Quantity (mg)/100 g dry matter
Water content 98.0±0.80
Ash matter 7950.0±50.00
Proteins 9882.0±8.00
Total sugar 53670.0±174.00
Lipid matter 2950.0±50.00
Total reducing power (vitamin C equivalent) 0.966±10.2800
Phenolic compounds 24.202±0.1060
Selenium 0.0108±0.0040
Calcium 1071.56±8.800
Magnesium 2217.54±3.170
Iron 9.82±0.920
Sodium 17.62±0.180
Copper 1.47±0.050
Adapted from Youkeu (2008).
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activity was performed. The author discovered that rats fed with
meal supplemented with 0.61%M. whitei were better adapted to
the physical effort with a performance difference of approxi-
mately 6% with respect to the control group.
3.3. Other traditional and general uses
The woody middle part of thicker roots is used as a
toothbrush. In folk medicine; the Luhya community of western
Kenya chew the roots for good luck before setting out to
perform a difficult task, as a cure for bewitchment, as a love
potion, to overcome hang-overs, a symbol of peace and a sign of
power (Mukonyi, 2002). In the past, the seeds were apparently
used as a potent arrow poison during hunting (Hutchings et al.,
1996). In South Africa, the stems are well beaten to yield long
and shiny strands tough enough to be used for the making of
ropes (Crouch et al., 1998a). As the brightly coloured flowersTable 3
Physicochemical and nutritional analysis of the roots and leaves of Mondia
whitei.
Parameters Quantity (mg/g)
Roots Leaves
Potassium 11.34 32.05
Sodium 5.61 24
Magnesium 1.40 2.83
Calcium 3.08 8.25
Iron 0.20 0.43
Zinc 0.03 0.07
Copper 0.003 0.06
Manganese 0.64 0.05
Cadmium and lead Trace Trace
Crude protein 4.35 21.8
Beta carotene 0.004 0.022
Thiamine 0.78 3.70
Niacin 0.52 8.15
Riboflavin 0.62 2.45
Fructose 0.008 0.015
Xylose 9.17 18.70
Glucose 2.40 9.0
Adapted from: www.infonet-biovision.org-mondia.are very attractive (Fig. 1C), it is highly recommended for
cultivation as a garden plant thereby adding to its horticultural
potential. It is a vigorous, fast-growing plant which makes it
ideal to cover trellises (Ross, 1978). Based on the sweet vanilla-
like flavour, Van Wyk and Gericke (2000) predicted that
M. whitei has the potential to be a novel African fragrance or
spice. Similarly, Crouch et al. (1998a) highlighted that the
missionary, Father Gerstner, described the taste of the roots as
first bitter then afterward sweet. This is reminiscent of vanilla,
ginger, marzipan, cinnamon and liquorice (Crouch et al.,
1998a). Therefore, the aromatic roots of M. whitei could
become a useful food-flavouring agent.
4. Chemical and phytochemical studies
4.1. Compounds isolated from M. whitei
Despite its long use, only a few studies exist on the isolation
of bioactive compounds fromM. whitei. The most common and
well-known compound isolated from M. whitei is 2-hydroxy-4-
methoxybenzaldehyde (5) which is a potent tyrosinase inhibitor
(Kubo and Kinst-Hori, 1999). The compound has also been
isolated from M. whitei by earlier researchers as highlighted by
Koorbanally et al. (2000). In addition, the authors reported for
the first time, the isolation of isovanillin (6), previously thought
to be synthetic from M. whitei. Subsequently, the first report of
the isolation of coumarins and coumarinolignan as well as
chlorinated coumarinolignan from the genus Mondia was
reported (Patnam et al. 2005). Recently, bioassay guided
isolation led to the isolation of (−)-loliolide (4), which showed
affinity to SERT in a binding assay (Neergaard et al., 2010).
The structures of some compounds (1–6) that have been
isolated fromM. whitei are depicted in Fig. 2. A number of other
compounds have also been isolated from M. whitei as stated by
other authors (Koorbanally et al., 2000; Patnam et al., 2005).
Relative to the high number of uses in traditional medicine as
well as the published articles on the preliminary screening of the
crude extracts, the number of isolated compounds is rather
small. Particularly, investigations onM.whitei as an aphrodisiac
have been extensive yet; the compound(s) responsible for the
observed effects, both in vitro and in vivo, remain to be isolated.
This leaves us with the challenge to conduct more stringent
research to isolate and identifymore novel bioactive compound(s)
from this species.
4.2. Phytochemical studies of M. whitei
A recent qualitative phytochemical analysis of ethanol
extract of M. whitei indicated the presence of reducing sugars
and triterpenes, however, other essential phytochemical groups
such as alkaloids, flavonoids, phenolics and saponins were not
detected (Quasie et al., 2010). Subsequently, Abdou Bouba
et al. (2010) reported the presence of phenolics (6.40 g
GAE/100 g DW), flavonoids (2.99 g/100 g DW) and tannins
(0.073 g/100 g DW) in this species. The authors further reported
antioxidant activity of the extract via its high hydroxyl radical
scavenging activity. Etoundi et al. (2010) detected a phenolic
Fig. 2. Chemical structures of some compounds isolated from Mondia whitei.
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extracts. Some scholars have suggested that the presence of a
wide range of plant secondary metabolites such as phenolics,
flavonoids and tannins in plants have a direct correlation to the
exhibited biological activities. Ndhlala et al. (2010a) for
instance, attributed antioxidant bioactivity to the presence of
phenolics in the plant. Hence, these plant secondary metabolites
detected inM. whitei could have partially contributed to some of
the observed bioactivities. An investigation of the physico-
chemical characteristics of M. whitei has also been reported
(Youkeu, 2008). Based on the results outlined in Tables 2 and 3,
M. whitei can easily serve as essential mineral and vitamin
supplements. However, there are high levels of disparities in
some of the parameters (for example, values for calcium,
magnesium) reported in Tables 2 and 3 and this remains a major
concern. There are a number of attributing factors such as
collection localities, seasonal variation effects and method of
analysis which could explain the observed disparities. More
studies are strongly recommended taking these factors into
account as well as using more sensitive equipment.
5. Conservation strategies for M. whitei
Okigbo et al. (2008) defined conservation as “a process
involved in the preservation and careful management of the
environment as well as natural resources to prevent neglect,
over-exploitation and destruction”. Globally, most natural
resources especially medicinal plants are under strain due to
increasing urbanisation and increased demand by the population
(Okigbo et al., 2008; Zschocke et al., 2000). This high demand
has led to indiscriminate harvesting and over-exploitation of the
natural flora within all ecosystems (Cunningham, 1997). In
South Africa, the problem of medicinal plant over-exploitation
is not a recent one. As early as 1946, Father Jacob Gerstner, a
Zululand missionary, predicted the looming extinctions of
‘doomed’ plant species used for traditional medicine (Gerstner,1946). In particular, Jäger and Van Staden (2000) identified the
increased use of the non-renewable plant materials such as
roots, bulbs and bark as the major contributing factor in the
decline of most species in the wild.
M. whitei is a slow-growing plant that takes about 15 years to
attain a tuber of sufficient size for consumption (McGeoch, 2004).
The ecological implications of intense harvesting of such a slow-
growing plant to satisfy the ever increasing demand are that
harvesting from the wild is unsustainable and the species may
become threatened. Indeed, the plant is reported to be scarce and
difficult to locate in the wild (Nichols, 2005). Around 1898, local
extermination ofM. whitei had been recorded in the Durban area
of South Africa due to collection of its roots (Crouch et al.,
1998a). In the past, M. whitei was protected by conservation
strategies such as traditional seasonal restriction on harvesting the
species and taboo against the gathering of traditionalmedicines by
menstruating women. Nevertheless, as a result of the cultural
change, increased entry of more amateur gatherers into the
medicinal plant trade due to rising unemployment levels, these
ancient controls are rapidly breaking down (Cunningham, 1993).
According to the Southern African red data list,M. whitei used to
be listed as a vulnerable species (Victor, 2002) however, it has
now been elevated to endangered status (Red List of South
African Plants, 2009). Further evidence of the threats toM.whitei
was reported by Ndawonde et al. (2007), who listed the species as
one of the nine species that is scarce and threatened in Zululand
(KwaZulu-Natal Province, South Africa). In East Africa,
McGeoch (2004) also reported thatM. whitei has been classified
as an endangered species requiring immediate protection from
extinction due to over-exploitation.
Generally, South Africa has a low success rate in the use of
law enforcement for biodiversity conservation (Wiersum et al.,
2006). Therefore, a new approach that involves the stimulation
of medicinal plant cultivation has been recommended (Van
Staden, 1999; Wiersum et al., 2006). The domestication of
medicinal plants will create new opportunities such as
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pressure on the wild natural medicinal plant population (Jäger
and Van Staden, 2000). Ndawonde et al. (2007) identified M.
whitei as a popular plant species that can be easily propagated in
South African communal gardens to counter the problem of
extinction. This was demonstrated by using seeds, which easily
germinate after two weeks. Alternatively, tip cuttings can also
be used for propagation (Crouch et al., 1998b). Generally,
community based medicinal plant farming coupled with the
provision of subsidy and training in basic effective propagation
techniques would enhance conservation of medicinal plants. A
model example of this was implemented in India where Giridhar
et al. (2005) used triacontanol soil drenching to increase the
plant growth and yield of tubers, with enhanced flavour content,
of Decalepis hamiltonii Wight & Arn. plantlets. The authors
developed a micropropagation protocol used to produce a large
number of good plantlets which were given to the tribal people
in the hill region, providing them with both food and medicine.
Another approach is the use of plant part substitution as a
means for sustainable harvesting. Several workers have
recommended that the non-destructive medicinal plant part
particularly the leaves should be investigated for possible
bioactivity (Zschocke et al., 2000). Aremu et al. (2010) for
instance, reported a better anthelmintic activity in Cyathea
dregei leaf extracts than in the root which is frequently used in
traditional medicine. As evidenced in this review (Fig. 3), most
of the studies on M. whitei have focused on the root/root bark
extracts which is an indication of the high stress on the
underground plant part. Zschocke and Van Staden (2000) also
suggested that traditional healers should be encouraged to use
related plant species where similar biological activity has been
demonstrated. The use of the exotic Cinnamomum zeylanicum
to replace M. whitei for example, has long been suggested by
Cunningham (1988). Therefore, it is necessary to investigate a
possible replacement species for similar biological activities
which M. whitei has exhibited.
Furthermore, South African scientists have attempted to
overcome the challenges of possible extinction of M. whiteiFig. 3. The frequency of the various organ parts used in the investigation of
Mondia whitei efficacy in published papers.through the use of biotechnological techniques. Tissue culture
regenerated plantlets are ideal for mass propagation of many
species such as M. whitei due to the numerous advantages
associated with in vitro techniques. Using the micropropagation
technique, an estimated 2000 plantlets could be produced from
a single seed after 7–8 subculture cycles at 4–6 week intervals.
Subsequently, these plantlets were easily rooted after 3 months
(McCartan and Crouch, 1998). Zobolo et al. (2009) also
successfully rooted M. whitei shoot cuttings in naphthalene
acetic acid (NAA) of varying concentrations. It was observed
that shoot cuttings cultured in 0.5 mg/l NAA were significantly
higher (pb0.05) in terms of the number of roots as well as the
root length. Nevertheless, the use of new and more potent plant
growth hormones such as the meta-topolins to enhance the
efficiency of the micropropagation protocols is pertinent
(Werbrouck, 2010). Presently, we are investigating the effects
of the meta-topolins as well as the application of hairy root
culture in M. whitei to maximise the production of the main
secondary metabolite, 2-hydroxy-4-methoxybenzaldehyde.
Generally, hairy root cultures are characterised by high
biosynthetic capacity and genetic fidelity as well as biochemical
stability (Toivonen, 1993). Although more expensive compared
to chemical synthesis, hairy root culture in M. whitei serve as a
natural source and may offer an alternative prospect for the
investigation of biosynthetic pathways and commercial pro-
duction of secondary metabolites such as 2-hydroxy-4-
methoxybenzaldehyde.
6. Economic status and commercial prospects of M. whitei
6.1. Economic status of M. whitei
Approximately 80% of the population in Asian and African
countries depend on traditional medicine for primary healthcare
(WHO, 2008). In the last two decades, the developed and
developing countries have witnessed a significant rise in the
demand for herbal medicines with global sales estimated at US$
60 billion (Hoareau and DaSilva, 1999). This is evidenced in
the expansion of scientific research relating to traditional
medicine and transnational markets for traditional medicinal
products. The trade of medicinal plants is increasing locally,
regionally and internationally (Marshall, 1998).
In most countries whereM. whitei occurs, there is no detailed
data on the harvest and trade of the species. A recent rapid
appraisal, however, indicated that the species wholesales for
between US$ 0.20–0.30/kg and retails at more than US$ 2/kg. In
Kenya, fresh roots were sold for US$ 7–12/kg (Mukonyi et al.,
2002). M. whitei collected by gatherers from natural forests can
generate an estimated US$ 3600 per year (McGeoch et al.,
2008). In Uganda, the average price per piece (0.01–0.02 m in
diameter and 0.3–0.4 m in length) or kg of roots increases from
the collectors (US$ 0.60/kg), middlemen (US$ 1.20/kg) and
finally to the retailers (US$ 1.50/kg) (Agea et al., 2008). To the
best of our knowledge in South Africa however, there is no
available published data on the average price for M. whitei.
Therefore, the contribution of this species to socio-economic
livelihoods especially in South Africa requires investigation.
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In South Africa, Mander et al. (1996) identified the lack of
understanding with respect to the cultivation and economics of
producing useful indigenous plants especially the medicinal
species as one of the most limiting factors in their commercia-
lisation. The authors observed that the producers do not engage
in commercialisation because there is no indication of the
potential profit from producing plants for local and international
markets. In KwaZulu-Natal, however, commercialisation of
indigenous plants seems to be well developed in the informal
sector, with a large and active trade all year round (Mander,
1998). Makunga et al. (2008) also acknowledged that the
informal sector was generally well-established but still
remained an ‘underground economy’. The authors highlighted
and strongly recommended the need to explore the untapped
potentials of the formal medicinal sector. ForM. whitei,most of
the available studies and literature focuses on the pharmacol-
ogy, taxonomy and nutritional aspects only. In Kenya, aMondia
tonic® (rich in vitamins and essential elements) has been
registered as a food supplement with the Kenya Bureau of
Standards, and with the Kenya Industrial Property Institute
(Mukonyi et al., 2002). In contrast with modest commercialisa-
tion of M. whitei in Kenya, the commercial potentials of
M. whitei in South Africa have remained unexploited even for
medicinal purposes. Evidence suggests that the demand for
traditional medicines continues to grow in South Africa
(Makunga et al., 2008). This has been attributed to the growing
human population, the low employment growth rate, the influx
of foreigners seeking work, and the limited resources of the
government to service primary health care. In addition, the
strong cultural attachment by many communities to traditional
practices, even within modernised urban settings, sustains the
demand for traditional plant products (Mander et al., 1996;
Mander et al., 2007). Despite the high utilisation of the species
in South Africa, the lack of commercialisation of the species is
worrisome and remain a major question that deserve more
stringent studies.
6.2.1. Potential in pharmaceutical and nutraceutical industries
As evidenced in this review, the number of studies onM.whitei
efficacy against various ailments is increasing. Diseases such as
erectile dysfunction, epilepsy, depression, inflammation and
microbial infection are of great concern worldwide. Erectile
dysfunction which has remained rampant among men aged
40–70 years is the inability to achieve and maintain an erection
sufficient to permit satisfactory sexual intercourse because of some
physiological and psychological factors (Lue, 2000; Martey and
He, 2010). Using various approaches and assay techniques
(Table 1), different researchers have investigated the efficacy of
M. whitei on erectile dysfunctions. Most of the authors observed
that extracts fromM. whitei have a significant positive aphrodisiac
effect on sexual drive thereby attenuating erectile dysfunction.
Watcho et al. (2007b) for instance, reported that the root extracts
caused an increase in mount, intromission and erectile frequencies
of inexperienced male rats. Although the majority of the
investigation of aphrodisiac activity of M. whitei is credited to theWatcho's group, other research groups have also been involved in
recent times (Gundidza et al., 2009; Quasie et al., 2010). Besides
the aphrodisiac activities, there have also been numerous studies on
the efficacy of M. whitei on diseases such as epilepsy, depression
and mental disorders. According to WHO (2011), an estimated
50 million people worldwide have epilepsy, with almost 90% of
these people being in developing countries.M. whitei extracts has
exhibited noteworthy effects on these diseases as reported in many
published articles (Nielsen et al., 2004; Pedersen et al., 2006) and
more active research is on-going. Tyrosinase is postulated to play a
role in the formation of neuromelanin in the human brain and could
be essential to dopamine neurotoxicity in addition to contributing to
the neurodegeneration associated with Parkinson's disease (Nihei
et al., 2004). However, it has been observed that 2-hydroxy-4-
methoxybenzaldehyde is a potent tyrosinase inhibitor; therefore,
M. whitei has the potential to combat the above mentioned
problem owing to the inhibitory compound present in the species.
The efficacy of M. whitei against microbial and helminth
infections has been studied (Matu and Van Staden, 2003; Sparg
et al., 2000). Most of the published results especially the
antibacterial activities (Table 1) were not promising, however
Sparg et al. (2000) observed a moderate anti-schistosomiasis
activity of the water extract (roots). Hence, we suggest the need
for further investigation of antimicrobial efficacy of M. whitei
on other microbial strains as M. whitei is widely used against
microbial related ailments.
The use ofM. whitei against most of these devastating diseases
coupled with the active research serves as potential ethnopharma-
cological leads to the discovery of novel and more efficient
therapeutics. Considering the number of studies on M. whitei, the
possibility of discovering new compound(s), which would be of
high therapeutic value, cannot be overlooked. In event of such a
discovery, it will lead to more interest from large pharmaceutical
companies, both local and international, with the sole purpose of
accessing large volumes of plant material. In terms of the
nutritional potentials, M. whitei could serve as another natural
source of essential mineral and vitamin supplements. Similarly,
Youkeu (2008) suggested the utilisation of M. whitei as an
alternative food supplement to enhance the performance of
sportsmen and women without the fear of a ban associated with
drug doping.
6.2.2. Potential in cosmeceutical and agricultural industries
The enzyme tyrosinase is responsible for melanisation in
animals and regulates melanogenesis in mammals. Abnormal
melanin pigmentation such as freckles and melasma are
considered by humans to not be aesthetically pleasing. However,
these problems can be partially suppressed by deactivating
tyrosinase. As various papers suggest that M. whitei contains
tyrosinase inhibitor, there is great potential for it in the cosmetic
industry. The importance of this unusual phenolic compound,
2-hydroxy-4-methoxybenzaldehyde has been emphasised, char-
acterised and quantified in Hemidesmus indicus (L.) Schult.
(Sircar et al., 2007). Furthermore, the insecticidal activity of the
compound was investigated using the roots of D. hamiltonii and
it was demonstrated against three coleopteran stored product
pests (George et al., 1999). The authors reported potent
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simplicity of its application, retention of viability of seeds and
the low toxicity. Both D. hamiltonii and M. whitei contain
2-hydroxy-4-methoxybenzaldehyde, which indicates thatM.whitei
could be used as an insecticide. Interestingly, these two species
(H. indicus and D. hamiltonii) have a number of similarities with
M. whitei in addition to being a member of the same sub-family
Peroplocoideae. Hence, the chances of successful application of
similar techniques and derived use from the two species are high
with M. whitei.
7. Concluding remarks
M. whitei is a popular medicinal plant in traditional medicine
hence; scientists have investigated the extracts for activities
such as aphrodisiac, antidepressant, anti-inflammatory, anti-
bacterial and antiepileptic. However, most of the studies
focused on the aphrodisiac activity efficacy (Table 1). To a
certain extent, the traditional uses of M. whitei have been
validated as shown in the interesting results from the various in
vitro and in vivo studies examined in this review. The various
pharmacological activities evident in the studies provide
scientific support for the wide usages in traditional medicine.
The favourable results also serve as an indication of the great
economic potential of M. whitei in view of the possibility of
isolation of novel compounds. Nevertheless, more intensive
phytochemical studies, especially on bioactivity guided isola-
tion of the new compounds would enhance the economic
potential of M. whitei.
Mutagenic and toxic effects of M. whitei have not really
received enough attention, only a few preliminary reports of its
safety exist (Watcho et al., 2001). In terms of toxicity, most
plant species used in traditional medicine are generally assumed
to have low toxicity due to their long-term consumption by
humans and animals (Luseba et al., 2007; Verschaeve and Van
Staden, 2008). M. whitei has a long history of traditional use,
with no reports of any serious side effects, suggesting that the
species can be considered as generally safe. Recent investiga-
tions, however, have revealed that many plants used as food,
medicine or herbal concoction do have mutagenic or toxic
effects when examined in more detail (Fennell et al., 2004;
Ndhlala et al., 2010b). Therefore, both preliminary and
exhaustive toxicology tests/adverse effects of M. whitei are
still pertinent because most of the available safety evaluations
remain inadequate and inconclusive.
In addition, themonitoring and follow-up in cases of perceived
over-exploitation of vulnerable species such asM. whitei are rare.
Some long-standing proposals for sustaining the industry that
include encouraging domestication, providing incentives for
sustainable harvesting aswell asmonitoring and enforcing the law
which to date have been made without much result (Mander et al.,
1996).M. whitei is an example of a typical African species with the
aforementioned neglects. The species is very useful and is
becoming rare in thewild with fear of extinction in time. Therefore,
this review highlighted the valuable, untapped potential as well as
possible conservation strategies of the species. For instance, there is
need to strengthen ancient cultural practices that ensure sustainablemanagement, key community members such as the headmen,
traditional community leaders and traditional community police
officers could be vital in the enforcement of laws against
indiscriminate harvesting of the species (Hamilton, 2004).
Furthermore, rigorous studies to evaluate possibilities of sustain-
able harvesting of this species from the wild have been
recommended (Lamidi and Bourobou Bourobou, 2010). In order
to meet the escalating demand for M. whitei especially with the
possibility of its commercialisation in South Africa, there would be
a need to stimulate the small and medium scale cultivation of this
species in regions that support its good growth. From a plant
biotechnologist point of view, tissue culture techniques remain an
ideal process for the mass micropropagation of M. whitei. In
addition, a more stringent investigation to increase the production
of the essential secondarymetabolites via hairy root culture isworth
pursuing. A comprehensive comparative analysis of secondary
metabolite yields as well as the pharmacology of the resultant hairy
roots will be highly valuable data for commercial purpose (Nigro
et al., 2004). The promising economic potential ofM. whiteiwith
the possibility of the development of a commercial product will
greatly benefit the indigenous people and the South African
economy. There will be an increase in demand by both the local
and international markets leading to the commercial cultivation of
the plant not only in South Africa, but also in neighbouring
countries. Furthermore, it will generate additional income in terms
of patent rights for the people who have been the custodians of the
indigenous knowledge. Lastly, the attractive nature of theM.whitei
flowers makes it a species with horticultural potential in both local
and overseas markets; however it remains an attractive area to be
fully considered and exploited by researchers.
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